Quality of Life  >>  BIAsp 30 (biphasic insulin aspart 30/70 biosimilar)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BIAsp 30 (biphasic insulin aspart 30/70 biosimilar) / Novo Nordisk
IMPROVE Life, NCT00696163: Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes

Completed
N/A
24975
RoW
biphasic insulin aspart 30, NovoMix® 30, BIAsp30
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 2
03/09
03/09

Download Options